Test Price
2,800 AED✅ Home Collection Available
MGME1 Gene Mitochondrial DNA Depletion Syndrome Type 11 Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed physicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MGME1 gene NGS test identifies pathogenic variants causing Mitochondrial DNA Depletion Syndrome Type 11, a severe autosomal recessive neurodegenerative disorder with infantile onset. This targeted analysis empowers neurologists, clinical geneticists, and pediatric specialists to deliver precise diagnosis, accurate prognosis, and informed family planning. Our methodology utilizes targeted high-depth next-generation sequencing (NGS) with orthogonal Sanger confirmation to ensure unambiguous detection of point mutations and small insertions or deletions.
| Feature | Our MGME1 NGS Test | Mitochondrial DNA Panel (Common Alternative) |
|---|---|---|
| Precision | >99.9% sensitivity for MGME1 point mutations & indels | Variable coverage; may miss low-level heteroplasmy |
| Method | Targeted high-depth NGS with orthogonal Sanger confirmation | Broad NGS without mandatory confirmatory testing |
| Turnaround | 3 – 4 Weeks | 6 – 8 Weeks |
| Clinical Utility | Single-gene depth ensures unambiguous diagnosis | Genes of secondary relevance may dilute focus |
Sample Types Accepted: Whole Blood (EDTA), Extracted DNA, or One Drop of Blood on FTA Card.
Pre-Test Requirement: A clinical history review and a genetic counselling session to construct a family pedigree of MGME1-related disorders.
Physician Insight & Safety Protocols
"A precise genetic diagnosis is the cornerstone of personalized management for mitochondrial disorders. Our integrated approach, combining high-depth NGS with careful clinical correlation, provides the clarity needed for prognosis and family planning. We ensure compassionate, informed support throughout your diagnostic journey."
Medication Safety Advisory
Patients and referring physicians must not alter or discontinue any prescribed therapeutic regimens based solely on preliminary genetic findings. All medication adjustments require direct consultation with the managing specialist. Continue all prescribed treatments unless explicitly advised otherwise by a licensed physician.
Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: Test requires a referral from a licensed neurologist or clinical geneticist and documented pre-test genetic counselling. Self-referred samples without clinical context will be rejected.
- Emergency Red Flags: If the patient experiences sudden loss of motor milestones, respiratory distress, refractory seizures, or acute metabolic decompensation, seek emergency medical intervention immediately.
Patient FAQ & Clinical Guidance
1. What is the MGME1 gene test and why is it performed?
This test identifies disease-causing mutations in the MGME1 gene responsible for mitochondrial DNA depletion syndrome type 11, a devastating pediatric neurodegenerative condition. It confirms diagnosis, guides medical management, and enables accurate genetic counseling for at-risk families. Early molecular confirmation can avoid diagnostic odysseys.
2. How accurate is the NGS test for MGME1 gene mutations?
Our test delivers greater than 99.9% diagnostic sensitivity for MGME1 point mutations and small insertions/deletions, confirmed by orthogonal Sanger sequencing. This exceeds typical panel-based detection rates, ensuring clinicians receive definitive results for patient management and family decisions.
3. What are the sample requirements and turnaround time?
You can provide a whole blood sample (EDTA), extracted DNA, or a single drop on an FTA card. Reports are issued within 3 to 4 weeks. A mandatory pre-test genetic counselling session ensures appropriate consent and pedigree documentation.
4. How does home collection work for this genetic test?
Our VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM across all Emirates. A trained phlebotomist visits your home using temperature-controlled cold-chain logistics to ensure sample integrity. Contact our billing team via WhatsApp for insurance verification and scheduling.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility is ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | MGME1 Gene NGS Test (Mitochondrial DNA Depletion Syndrome Type 11) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Targeted High-Depth Next-Generation Sequencing (NGS) with Orthogonal Sanger Confirmation |
| ICD-10-CM Code | E88.41 |
| LOINC Code | 81200-1 |
| DHA Facility License & Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DHA License No. 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians